InsidersTradesSigma
Glenmark Pharmaceuticals Limited Stock: price and insider trades · India · SEBI (PIT + SAST)
Track the Glenmark Pharmaceuticals Limited share price and the full insider trade history of the company, a publicly traded company based in India. Shares are listed on IN IN, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Glenmark Pharmaceuticals Limited has published 13 reports. Market capitalisation: €434.6bn. The latest transaction was disclosed on 22 September 2023 (Sale). Among the most active insiders: Glenn Mario Saldanha. All data is openly available.
13
Insider Decl.
0
Thresholds
€203,926
7 ops.
Buy Volume
€27,554
6 ops.
Sell Volume
10Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 8,969 of 26,182 companies
59.5
score / 100
Value40
Quality79
FCF yld3.2%
Earn yld2.1%
EV/EBITDA23.5x
ROE14%
Gross mgn72%
Net mgn8.1%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 22 September 2023
Declarations13 total
1,000 shares@ ₹852.0040.0% of flowEquity SharesSEBI:7c43f029fcf65d701002d87cbc38f4b76c05691e
1,000 shares@ ₹852.0040.0% of flowEquity SharesSEBI:4735f3b198350556570238ed4d2ffa4d36737a5f
500 shares@ ₹851.0220.0% of flowEquity SharesSEBI:e66100d169abd1b49336835c9bcfd5956cdd6833
250 shares@ ₹490.192100.0% of flowEquity SharesSEBI:a283ff59f1d01e5f26fe4c410f3339b8dd4e629e
Ideal exit: 20 Aug 2022 (T+270)
559 shares@ ₹535.6834100.0% of flowEquity SharesSEBI:ad6a757c300c502fcdefcf162081d13e883d157f
20,000 sharesEquity SharesSEBI:e06c089566a41c4b5ee160b60fbae8e1e10c0e7b
Ideal exit: 24 Jun 2022 (T+270)
10,000 sharesEquity SharesSEBI:1511c0d568f366fa2576ec8a989296183f4d31d3
10,000 sharesEquity SharesSEBI:a1e94610183e8e27382d484204aff805092b4751
9,800 shares@ ₹513.015230.4% of flowEquity SharesSEBI:32da8d7c912f1d4d9db504832ae09f596a698347
Ideal exit: 21 Jun 2022 (T+270)
1,950 shares@ ₹512.8651100.0% of flowEquity SharesSEBI:da3603681fcec6d45c53b1c6d36c6d3f53bdf9e4
Ideal exit: 19 Jun 2022 (T+270)
7,800 shares@ ₹640.000.0000% mcap42.4% of flowEquity SharesSEBI:fe9844636b32f99c393cfd6c43b8d98c8ab54355
Ideal exit: 20 Mar 2022 (T+270)
2,800 shares@ ₹641.85610.0000% mcap15.2% of flowEquity SharesSEBI:8de2ea524f0611f5960938f5b20074c58d0281b6
Ideal exit: 19 Mar 2022 (T+270)
7,870 shares@ ₹636.84160.0000% mcap42.4% of flowEquity SharesSEBI:cbe4bc773724e8e0f53f03e1d6508c57011868b5
Ideal exit: 6 Mar 2022 (T+270)
13 of 13 declarations